You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 6, June 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (17)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology, Other
 •Alert me on articles by topic

Familial Paroxysmal Dystonic Choreoathetosis

Clinical Findings in a Large Japanese Family and Genetic Linkage to 2q

Hirotaka Matsuo, MD; Keiko Kamakura, MD, PhD; Masaaki Saito, MD, PhD; Masamichi Okano, MD; Terumasa Nagase, MD; Yutaka Tadano, MD; Ken-ichi Kaida, MD; Akira Hirata, MD; Norikazu Miyamoto, MD; Toshihiro Masaki, MD, PhD; Ryohji Nakamura, MD, PhD; Kazuo Motoyoshi, MD, PhD; Hajime Tanaka, MD, PhD; Shoji Tsuji, MD, PhD

Arch Neurol. 1999;56:721-726.

Background  Paroxysmal dystonic choreoathetosis (PDC) is a rare familial movement disorder that has been mapped to chromosome 2q31-36.

Objective  To study the first Japanese family with PDC clinically and genetically.

Patients and Methods  We studied a large Japanese family in which at least 17 members in 6 generations have been affected by PDC. We interviewed and examined 26 family members, 8 of whom revealed choreoathetosislike and dystonialike involuntary movement and 1 of whom revealed no involuntary movement but only muscle stiffness such as the aura of paroxysmal dystonic choreoathetosis (PDC). Genetic linkage studies of this family were carried out with polymorphic DNA markers.

Results  The attacks of involuntary movement or muscle stiffness were precipitated by ovulation, menstruation, emotional stress, or caffeine or alcohol ingestion. Magnetic resonance imaging of the brain revealed no abnormalities. Clonazepam therapy was effective for reducing the attacks, and ingestion of garlic was believed by patients to be effective for softening the attacks. An affected woman with only muscle stiffness showed remission after hysterectomy for hysteromyoma. This woman also had the disease haplotype and transferred it to her typical PDC-affected daughter. Maximal pairwise logarithm of odds scores exceeding 2.00 were obtained at D2S2250, D2S1242, D2S377, D2S2148, and D2S126. The PDC gene was demonstrated by linkage analyses to be located in a 15.3-centimorgan interval lying between D2S371 and D2S339 based on pairwise and multipoint logarithm of odds scores and obligate recombination events in affected individuals.

Conclusions  Linkage of PDC to chromosome 2q32-36 was confirmed in a Japanese family. The clinical characterizations of this family with PDC include that ovulation seems also to be a precipitating factor of the attacks and that hysterectomy seems to be effective for softening the attacks. Although low-dose clonazepam treatment was most effective, garlic use was believed by affected members to be effective for softening the attacks. Furthermore, based on the results of clinical and genetic analyses, we suggest that muscle stiffness without involuntary movement may represent a forme fruste of PDC.


From the Third Department of Internal Medicine, National Defense Medical College, Saitama (Drs Matsuo, Kamakura, Okano, Nagase, Tadano, Kaida, Hirata, Miyamoto, Masaki, Nakamura, and Motoyoshi); and the Department of Neurology, Brain Research Institute, Niigata University, Niigata (Drs Saito, Tanaka, and Tsuji), Japan.


RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(6):762-764.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Review: Diagnosis and treatment of paroxysmal dyskinesias revisited
Unterberger and Trinka
Therapeutic Advances in Neurological Disorders 2008;1:67-74.
ABSTRACT  

Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia
Bruno et al.
Neurology 2007;68:1782-1789.
ABSTRACT | FULL TEXT  

Presence of Alanine-to-Valine Substitutions in Myofibrillogenesis Regulator 1 in Paroxysmal Nonkinesigenic Dyskinesia: Confirmation in 2 Kindreds
Chen et al.
Arch Neurol 2005;62:597-600.
ABSTRACT | FULL TEXT  

The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway
Lee et al.
Hum Mol Genet 2004;13:3161-3170.
ABSTRACT | FULL TEXT  

Myofibrillogenesis Regulator 1 Gene Mutations Cause Paroxysmal Dystonic Choreoathetosis
Rainier et al.
Arch Neurol 2004;61:1025-1029.
ABSTRACT | FULL TEXT  

The genetics of primary dystonias and related disorders
Nemeth
Brain 2002;125:695-721.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.